BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 30335982)

  • 1. Enzymatic Transition States and Drug Design.
    Schramm VL
    Chem Rev; 2018 Nov; 118(22):11194-11258. PubMed ID: 30335982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic transition states: thermodynamics, dynamics and analogue design.
    Schramm VL
    Arch Biochem Biophys; 2005 Jan; 433(1):13-26. PubMed ID: 15581562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition States, analogues, and drug development.
    Schramm VL
    ACS Chem Biol; 2013 Jan; 8(1):71-81. PubMed ID: 23259601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic transition states and transition state analog design.
    Schramm VL
    Annu Rev Biochem; 1998; 67():693-720. PubMed ID: 9759501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes.
    Schramm VL
    Annu Rev Biochem; 2011; 80():703-32. PubMed ID: 21675920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme inhibitors as chemical tools to study enzyme catalysis: rational design, synthesis, and applications.
    Hiratake J
    Chem Rec; 2005; 5(4):209-28. PubMed ID: 16041744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic transition state poise and transition state analogues.
    Schramm VL
    Acc Chem Res; 2003 Aug; 36(8):588-96. PubMed ID: 12924955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition state analysis and inhibitor design for enzymatic reactions.
    Schramm VL; Horenstein BA; Kline PC
    J Biol Chem; 1994 Jul; 269(28):18259-62. PubMed ID: 8034566
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic transition states and transition state analogues.
    Schramm VL
    Curr Opin Struct Biol; 2005 Dec; 15(6):604-13. PubMed ID: 16274984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition state analogues for enzymes of nucleic acid metabolism.
    Schramm VL
    Nucleic Acids Res Suppl; 2003; (3):107-8. PubMed ID: 14510403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition States and transition state analogue interactions with enzymes.
    Schramm VL
    Acc Chem Res; 2015 Apr; 48(4):1032-9. PubMed ID: 25848811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic catalysis and transition-state theory.
    Lienhard GE
    Science; 1973 Apr; 180(4082):149-54. PubMed ID: 4632837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition state and multisubstrate analog inhibitors.
    Radzicka A; Wolfenden R
    Methods Enzymol; 1995; 249():284-312. PubMed ID: 7791615
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of the molecular electrostatic potential surface of an enzymatic transition state with novel transition-state inhibitors.
    Horenstein BA; Schramm VL
    Biochemistry; 1993 Sep; 32(38):9917-25. PubMed ID: 8399161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational aspects of inhibitor design: enzyme-substrate interactions in the transition state.
    Wolfenden R
    Bioorg Med Chem; 1999 May; 7(5):647-52. PubMed ID: 10400319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives.
    Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J
    Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrophosphate interactions at the transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.
    Zhang Y; Schramm VL
    J Am Chem Soc; 2010 Jun; 132(25):8787-94. PubMed ID: 20527751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of transition-state analogues as potent enzyme inhibitors with therapeutic applications.
    Amyes TL; Richard JP
    ACS Chem Biol; 2007 Nov; 2(11):711-4. PubMed ID: 18030986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.
    Ducati RG; Namanja-Magliano HA; Schramm VL
    Future Med Chem; 2013 Jul; 5(11):1341-60. PubMed ID: 23859211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisubstrate adduct inhibitors: drug design and biological tools.
    Le Calvez PB; Scott CJ; Migaud ME
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1291-318. PubMed ID: 19912064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.